CN104984248A - Traditional Chinese medicinal compound for treating hepatitis - Google Patents
Traditional Chinese medicinal compound for treating hepatitis Download PDFInfo
- Publication number
- CN104984248A CN104984248A CN201510420076.4A CN201510420076A CN104984248A CN 104984248 A CN104984248 A CN 104984248A CN 201510420076 A CN201510420076 A CN 201510420076A CN 104984248 A CN104984248 A CN 104984248A
- Authority
- CN
- China
- Prior art keywords
- radix
- traditional chinese
- rhizoma
- chinese medicinal
- medicinal compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The purpose of the invention is to provide a traditional Chinese medicinal compound for treating hepatitis. The traditional Chinese medicinal compound has the efficacies of softening and nourishing the liver, invigorating blood circulation and dissolving stasis, relieving internal heat and detoxifying to eliminate jaundice, inducing diuresis to eliminate dampness, eliminating swelling, invigorating spleen and stomach and nourishing kidney, and can substantially improve the restoration and disease resistance functions of liver. The traditional Chinese medicinal compound comprises honeysuckle flower, Radix Astragali, Salvia miltiorrhiza, Rhizoma Atractylodis Macrocephalae, wolfberry fruit, Chinese angelica, isatis root, dragon's blood, Plantaginis Semen, radix bupleuri, Radix Pseudostellariae, Radix Curcumae Aromaticae, radix paeoniae rubra, white peony root, Radix Scutellariae, Herba Taraxaci, Rhizoma Polygoni Cuspidati, Capillary Wormwood Herb, Hedyotis diffusa, Rhizoma Alismatis, Fructus Gardeniae, Rheum officinale, Poria cocos in Yunnan and hawthorn fruit.
Description
Technical field
The present invention relates to a kind of Chinese medicine compound being used for the treatment of hepatitis, belong to pharmaceutical compounding techniques field.
Background technology
The hepatocellular degeneration caused due to a variety of causes is downright bad, and hepatic insufficiency can be called hepatitis.
As follows according to etiological classification: 1, viral hepatitis; 2 drug induced hepatitis; 3, alcoholic hepatitis; 4, autoimmune hepatitis; 5, toxic hepatitis; 6, fat hepatitis; 7, metabolic hepatitis; 8 Cryptogenic hepatitis (it is agnogenio).
Liver is that human body mainly detoxifies organ, and the noxious substance that the metabolism in external or human body produces will through liver process, and the material making noxious substance be called that nontoxic or dissolubility is larger is excreted by bile or urine again.But also have exception, after liver process, toxicity increases on the contrary.
The removing toxic substances principle of liver is: 1, chemical action; 2, secretory action; 3, cumulative action; 4, phagocytosis.Once liver itself over-burden, the metabolic function of liver can not be adapted to, just there will be certain damage, as hepatic necrosis or cytopathy or hepatic insufficiency or liver cirrhosis.
Because firm dirty function complexity is various, show also difference after being ill so obtain.The state of an illness has gently to be had heavily, and the course of disease has and acutely has chronic point.Therefore symptom variation multiterminal, symptom mostly substantially is loss of appetite, detests greasy, nausea and vomiting, abdominal distention diarrhoea, lassitude and weak, muscular soreness, jaundice, gingival hemorrhage, melena etc.
There is no special effect medicine therapeutic at present can use, hepatoprotective medicament categories is various, and its curative effect is not still affirmed, therapeutic scheme is disunity still, and therapeutic effect just delays the state of an illness, can not effect a radical cure.
We are in outpatient service to liver disease many decades, and the failure gone through many times just sums up more effective Therapeutic Method, and respond well clinically, cure rate is high.
Summary of the invention
The object of the invention is a kind of Chinese medicine compound being used for the treatment of hepatitis, there is easing the affected liver nourishing the liver, stomach is lived in blood circulation promoting and blood stasis dispelling, the jaundice eliminating that relieves internal heat, diuretic dampness, detumescence de-swelling, spleen invigorating, for dietetic therapy kidney, and can significantly improve the reparation of liver and disease-resistant function.
The present invention, according to the compatibility relationship of monarch, adopts pure Chinese medicine formula.
Monarch drug is: Flos Lonicerae, Radix Isatidis, Radix Scutellariae, Herba Taraxaci, Herba Hedyotidis Diffusae, Fructus Gardeniae, Rhizoma Polygoni Cuspidati, Radix Bupleuri, Radix Et Rhizoma Rhei.Object is heat-clearing and toxic substances removing, antibacterial removing heat from blood, soothing the liver antiinflammatory, hard masses softening and resolving;
Ministerial drug is: Radix Salviae Miltiorrhizae, Radix Curcumae, Radix Paeoniae Rubra, Sanguis Draxonis.Blood circulation promoting and blood stasis dispelling, granulation promoting hepatoprotective, jaundice eliminating;
Adjuvant drug is: the Radix Astragali, Radix Pseudostellariae, the Radix Paeoniae Alba, the Rhizoma Atractylodis Macrocephalae, Fructus Lycii, Radix Angelicae Sinensis, Fructus Crataegi.Object is rich in nutrition, spleen invigorating of nourishing blood, stomach function regulating help digestion, kidney is supported in nourishing the liver suppressing the hyperactive liver, blood fat reducing;
Medicine is made to be: Herba Hyperici Japonici, Herba Artemisiae Scopariae, Rhizoma Alismatis, PORIA from Yunnan of China, Semen Plantaginis.Object is diuretic dampness, liver heat removing detumescence, de-swelling.
Technical scheme of the present invention is achieved in that Chinese medicine compound of the present invention, it is characterized in that being made up of the Chinese medicine of following weight portion:
Flos Lonicerae 500g, Radix Astragali 1000g, Radix Salviae Miltiorrhizae 500g, Rhizoma Atractylodis Macrocephalae 500g, Fructus Lycii 500g, Radix Angelicae Sinensis 500g, Radix Isatidis 1000g, Sanguis Draxonis 800g, Semen Plantaginis 800g, Radix Bupleuri 800g, Radix Pseudostellariae 500g, Radix Curcumae 500g, Radix Paeoniae Rubra 500g, Radix Paeoniae Alba 500g, Radix Scutellariae 800g, Herba Taraxaci 1000g, Rhizoma Polygoni Cuspidati 500g, Herba Artemisiae Scopariae 1000g, Herba Hedyotidis Diffusae 800g, Rhizoma Alismatis 800g, Fructus Gardeniae 500g, Radix Et Rhizoma Rhei 500g, PORIA from Yunnan of China 500g, Fructus Crataegi 800g.
Claims (1)
1. be used for the treatment of a Chinese medicine compound for hepatitis, it is characterized in that being made up of the Chinese medicine of following weight proportion: Flos Lonicerae 500g, Radix Astragali 1000g, Radix Salviae Miltiorrhizae 500g, Rhizoma Atractylodis Macrocephalae 500g, Fructus Lycii 500g, Radix Angelicae Sinensis 500g, Radix Isatidis 1000g, Sanguis Draxonis 800g, Semen Plantaginis 800g, Radix Bupleuri 800g, Radix Pseudostellariae 500g, Radix Curcumae 500g, Radix Paeoniae Rubra 500g, Radix Paeoniae Alba 500g, Radix Scutellariae 800g, Herba Taraxaci 1000g, Rhizoma Polygoni Cuspidati 500g, Herba Artemisiae Scopariae 1000g, Herba Hedyotidis Diffusae 800g, Rhizoma Alismatis 800g, Fructus Gardeniae 500g, Radix Et Rhizoma Rhei 500g, PORIA from Yunnan of China 500g, Fructus Crataegi 800g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510420076.4A CN104984248A (en) | 2015-07-13 | 2015-07-13 | Traditional Chinese medicinal compound for treating hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510420076.4A CN104984248A (en) | 2015-07-13 | 2015-07-13 | Traditional Chinese medicinal compound for treating hepatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104984248A true CN104984248A (en) | 2015-10-21 |
Family
ID=54296227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510420076.4A Pending CN104984248A (en) | 2015-07-13 | 2015-07-13 | Traditional Chinese medicinal compound for treating hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104984248A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105456520A (en) * | 2015-12-29 | 2016-04-06 | 兖矿集团有限公司总医院 | Pharmaceutical formula for treating alcoholic liver disease and experimental method |
| CN105456517A (en) * | 2015-12-15 | 2016-04-06 | 彭国能 | Traditional Chinese medicinal composition and preparation for treating chronic hepatitis B and preparation method of preparation |
| CN106266807A (en) * | 2016-09-13 | 2017-01-04 | 胡敏权 | A kind of Chinese medicine composition of liver cirrhosis treating hepatitis B, chronic hepatic initiation and preparation method thereof |
| CN108210561A (en) * | 2016-12-13 | 2018-06-29 | 河南后羿实业集团有限公司 | To the Chinese medicine medicine that liver plays a protective role to and preparation method thereof |
-
2015
- 2015-07-13 CN CN201510420076.4A patent/CN104984248A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105456517A (en) * | 2015-12-15 | 2016-04-06 | 彭国能 | Traditional Chinese medicinal composition and preparation for treating chronic hepatitis B and preparation method of preparation |
| CN105456520A (en) * | 2015-12-29 | 2016-04-06 | 兖矿集团有限公司总医院 | Pharmaceutical formula for treating alcoholic liver disease and experimental method |
| CN106266807A (en) * | 2016-09-13 | 2017-01-04 | 胡敏权 | A kind of Chinese medicine composition of liver cirrhosis treating hepatitis B, chronic hepatic initiation and preparation method thereof |
| CN108210561A (en) * | 2016-12-13 | 2018-06-29 | 河南后羿实业集团有限公司 | To the Chinese medicine medicine that liver plays a protective role to and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101104069A (en) | Traditional Chinese medicine formula for treating liver (biliary) inflammation | |
| CN102552697B (en) | Chinese medicinal preparation for treating hand-foot-mouth disease | |
| CN103705596A (en) | Traditional Chinese medicine for reducing blood pressure and preparation method thereof | |
| CN104984248A (en) | Traditional Chinese medicinal compound for treating hepatitis | |
| CN103341079B (en) | Chinese medicine composition for treating acne | |
| CN102100872A (en) | Chinese medicine preparation for treating mastitis | |
| CN1103223C (en) | Chinese medicine for treating cholecystitis | |
| CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
| CN1060938C (en) | Chinese medicinal instant powder for treatment of B-hepatitis | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN101549136B (en) | Medicine for treating rheumatoid arthritis | |
| CN104645008A (en) | Traditional Chinese medicine for treating herpes zoster | |
| CN106692810A (en) | Traditional Chinese medicine formula for treating spleen deficiency and damp obstruction type gout | |
| CN101757468A (en) | Chinese medicinal preparation having hypotensive effect | |
| CN104127602A (en) | Traditional Chinese medicine for treating fatty liver | |
| CN103933470A (en) | Traditional Chinese medicine for treating gastric ulcer | |
| CN104173929A (en) | Traditional Chinese medicine for treating ulcerative colitis | |
| CN103301405B (en) | Traditional Chinese medicine for treating equine jaundice | |
| CN101897904A (en) | Chinese medicine preparation for treating hepatitis | |
| CN105232694A (en) | Traditional Chinese medicine for treating diarrhea, preparing method of traditional Chinese medicine for treating diarrhea and medicine product of traditional Chinese medicine for treating diarrhea | |
| CN105456821A (en) | Oral traditional Chinese medicine for treating eczema and preparation method thereof | |
| CN106668655A (en) | Traditional Chinese medicine formula for treating spleen asthenia and dampness retention gout | |
| CN104288689A (en) | Traditional Chinese medicine for treating mucocutaneous lymph node syndromes and preparation method of traditional Chinese medicine | |
| CN100577190C (en) | A kind of medicine for the treatment of cancer | |
| CN104857100A (en) | Traditional Chinese medicine prescription for curing chronic uremia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151021 |